🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse re...
Status
Completed
Location
Azienda Ospedaliera Universitaria Policlinico "P. Giaccone" Palermo
Start Date
2018-02-01
Trial ID
NCT06072404
Treatments Being Tested
This is a single-center, open-label, phase I clinical trial aimed to evalua...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-08-01
Trial ID
NCT05507606
Treatments Being Tested
The purpose of this study is to evaluate the safety, and tolerability of HL...
Status
Unknown
Location
Fukushima Medical University Hospital
Start Date
2007-03
Trial ID
NCT00639925
Treatments Being Tested
This study will test whether an experimental drug called Revlimid (lenalido...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
2005-04
Trial ID
NCT00109005
Treatments Being Tested
Ovarian clear cell carcinoma (OCCC) is one of the rare subtypes of ovarian ...
Status
Completed
Location
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Start Date
2021-04-07
Trial ID
NCT04735861
Treatments Being Tested
In patients treated for exudative age-related macular degeneration (AMD), d...
Status
Completed
Location
Centre Pôle Vision du val d'Ouest
Start Date
2020-05-27
Trial ID
NCT04395859
Treatments Being Tested
To study safety and efficacy of intravenous pump of recombinant human endos...
Status
Unknown
Location
Sichuan Provincial People Hospital
Start Date
2018-07-01
Trial ID
NCT03577392
Treatments Being Tested
This is a single-arm, open-label and exploratory clinical study of Anlotini...
Status
Unknown
Location
Jiangsu Province Hospital
Start Date
2019-06-10
Trial ID
NCT04052152
Treatments Being Tested
A number of studies suggest that the combination of PARP inhibitors and ant...
Status
Completed
Location
Sun Yat-sen University Cancer Cetntre
Start Date
2022-09-22
Trial ID
NCT05494580
Treatments Being Tested
This is an open-label, multi-center Phase II study of fluzoparib combined w...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Cetntre
Start Date
2023-10-18
Trial ID
NCT06063070
Treatments Being Tested